StemOn has been selected as a finalist in the research and innovation category of L'Oréal's open innovation program, "L'Oréal BIG BANG"through the "K-Startup X France Meetup Day" jointly hosted by the Ministry of SMEs and Startups and L'Oréal Korea.The company was chosen for the program in recognition of the innovativeness of its digital cell reprogramming technology-based personalized functional cosmetic ingredients.Through this program, StemOn is expected to receive various forms of support, including opportunities for technological collaboration with L'Oréal’s global brand team, as well as mentoring, consulting, marketing, and networking.In addition, the company plans to receive up to 200 million KRW in commercialization funding and a customized specialized program from the Ministry of SMEs and Startups.

STEMON participated in the 2025 China Beauty Expo (CBE 2025), held from May 12 to 14 in Shanghai, where it showcased its cutting-edge exosome-based skin regeneration technology. Unlike conventional skincare, STEMON’s approach leverages a scientific method that promotes regeneration at the cellular level, drawing strong interest from industry professionals. The company’s solution, particularly effective in skin recovery and anti-aging, received notable attention. STEMON aims to leverage this exhibition to strengthen its technological competitiveness and brand presence across China and the broader Asian market. Meanwhile, CEO Soonhak Kim successfully delivered a presentation on the company’s technology during the “Korea Pavilion New Product Launch – Beauty Day” event on May 13.

STEMON participated in DUBAI DERMA 2025, held in Dubai, UAE, from April 14 to 16, 2025, where it unveiled its advanced exosome-based technologies and skin regeneration solutions. During the exhibition, STEMON introduced a range of skincare products featuring its exosome technology, known for its effectiveness in skin repair and anti-aging, drawing significant attention from professionals in the medical and aesthetic fields as well as from visitors. Through this exhibition, STEMON aims to expand its presence in the global beauty market, including the Middle East, and actively pursue new partnership opportunities with local distributors and specialized clinics.

STEMON participated in COSME TECH TOKYO 2025, held from January 15 to 17, 2025, in Tokyo, Japan, where it presented its latest exosome technology and innovative beauty and skincare products. At the event, STEMON introduced exosome technology designed to enhance skin health and regeneration, drawing significant interest from industry experts and visitors. The company also showcased a variety of new beauty and skincare products, receiving positive feedback for their innovation. Through this exhibition, STEMON aims to expand its presence in the Japanese market and explore new partnership opportunities globally.

STEMON participated in Cosmoprof India 2024, held from December 5 to 7, 2024, in Mumbai, showcasing its groundbreaking exosome technology for the beauty and skincare industry. At the event, STEMON presented exosome-based solutions designed to enhance skin health and support regeneration, introducing new possibilities in the Indian market. Industry experts and visitors expressed significant interest in STEMON’s exosome technology and praised its innovative potential. As a leading innovator in the global beauty industry, STEMON looks forward to fostering new partnerships, including in the Indian market, through this event.

STEMON participated in the prestigious global beauty fair, Hong Kong CosmoProf, held from November 12 to 14, 2024, showcasing its groundbreaking exosome technology for the beauty and skincare industry. At the event, STEMON introduced exosome-based solutions designed to enhance skin health and support regeneration, presenting new possibilities in beauty care. Visitors from around the world and industry leaders showed great interest in the innovative potential of exosome technology, reacting enthusiastically to the showcase. STEMON continues to lead innovation in the beauty industry and looks forward to collaborating with global partners inspired by the potential of exosome technology. Stay tuned for more of STEMON’s efforts to redefine the future of beauty science!

PET FAIR SEA 2024 October 30th, 2024 to November 1st, 2024 Bangkok, ThailandSTEMON went to a PET FAIR SEA held in Bangkok, Thailand from Oct. 30th to Nov. 1st, 2024 to meet customers/future partners and showcase our ReproPet.At this event, STEMON collaborated with Mirae Medical, a valuable partner of STEMON in Thailand, to help promote the product to visitors from all over the world. Mirae Medical has a strong partnership with STEMON and has 100+ of clinical data with ReproPet. If you are interested in ReproPet and its clinical data, please see our medical device brochure as attachment below.

STEMON attended FAVA 2024(23rd Federation of Asian Veterinary Associations Congress) held in Daejeon Convention Center in South Korea from Oct. 25th to 27th, 2024. ReproPet, the first worldwide exosome-based wound dressing for animals, was introduced to customers. We are getting lots of clinical data and high demand of purchase from international customers. If you are interested in ReproPet and its clinical data, please see our medical device brochure as attachment below.